Cipla Ltd.’s quarterly profit it has fallen, estimates are lacking. The net profit of drug manufacturers fell by 45% compared to the same quarter, to 413.38 kroner in the quarter ended in March. Analysts compiled by Bloomberg estimated the metric at $ 621.3 million. Revenue decreased by 11% to HRK 4,606.45 million, compared to an estimate of HRK 4,999.3 million. Operating profit fell by 35% compared to the quarter to HRK 796.24 million – also lower than estimates by HRK 1,092.1 million.